📸 Galaxy Z Fold8's My FanCam tracks people in video

The My FanCam feature lets users automatically track a selected person in videos on the Galaxy Z Fold8 series. This capability is powered by AI technology from Samsung Research, integrated with the MX Business team. Users can instantly switch between subjects after an initial analysis, even in complex group videos. A major hurdle overcome was processing the AI workloads entirely on-device without needing a separate server. This allows fans and users to focus on special moments in various footage types. 🤳

🏦 HSBC joins giants in Nuvama Wealth acquisition race

Europe's biggest lender, HSBC, is now competing with several global private equity firms to buy Nuvama Wealth and Investment Ltd. The competition involves at least half a dozen players, including Brookfield and Warburg Pincus, targeting the asset. PAG relaunched the sale, which currently values the stake at Rs 17,336 crore based on its 53.98% holding. This deal is set to trigger an open offer for the remaining 26% of the company. The Indian wealth market is booming, projected to hit $1.7 trillion AUM by 2030. 💰

🚀 Irumudi hits 100 crore ROI early in 2026

Ravi Teja's film Irumudi is performing strongly at the Indian box office with positive word-of-mouth. The movie is in theaters in India, and it earned 6.6 crore on the second Monday, day 11. Overall, the film has collected 136.15 crore net, achieving an ROI of 101.15 crore by day 11. This makes it the first Telugu film of 2026 to reach a 100 crore ROI mark. It is expected to potentially cross the 200 crore net mark soon. 🤩

🩺 New device helps diagnose fainting causes better

An extended ECG monitoring protocol was tested for people with unexplained fainting, according to the ASPIRED trial. This study took place across several dozen hospitals in the U.K. The trial involved 2,234 randomized individuals, running from the index ED visit for 14 days. While reported fainting episodes remained similar, early monitoring significantly boosted arrhythmia detection and lowered all-cause death. Future studies like REMOSYNCED may provide further validation in different care settings. 🩺

🌟 Mamitha Baiju's 2026: Three 200 Crore Hits Streak

Mamitha Baiju has achieved a massive box-office streak in 2026 with three consecutive films crossing the 200 crore mark worldwide. This phenomenal run saw her star in Jana Nayagan, Suriya’s Vishwanath & Sons, and Bethlehem Kudumba Unit. Jana Nayagan, released in July, was Kollywood’s top grosser of 2026 at 320 crore+. Bethlehem Kudumba Unit, released last month, hit 200 crore+ in just 11 days. This incredible performance solidifies her status as a top South Indian actress for the coming years. 🎬

🎬 The Odyssey surpasses The Avengers at the box office

Christopher Nolan's The Odyssey has broken into the all-time top 15 highest-grossing movies worldwide. The Matt Damon-led film surpassed Furious 7 and The Avengers globally this weekend. As of the seventh weekend, its worldwide total reached $1.55 billion. This success shows strong audience willingness to attend theaters for quality cinema. The movie, released on July 17, is now ranked as the #14 highest-grossing film globally.

🤰 Asthma meds safe for pregnancy, but people stop taking them

A cohort study found that pregnant women using inhaled corticosteroids (ICS) in the first trimester had no higher risk of bad outcomes for mother or baby. This research was conducted in South Korea between 2009 and 2023, analyzing 2108 women with asthma. Despite guidelines, nearly two-thirds of these women stopped the treatment early on. Continuing ICS use was not linked to increased risks like preeclampsia or low birth weight. Clinicians must emphasize that maintaining asthma control during pregnancy is the recommended safest approach.

🔬 Grok 4.6 shows strong biosecurity skills

LatchBio analyzed Grok 4.6's biological capabilities and biosecurity performance using specialized benchmarks. The model proved the strongest in refusing disguised and hazardous tasks while still handling routine biological work. Specifically, Grok 4.6 scored above 50% on both the BioSecBench-Refusal and routine compliance measures. On the BioSecBench-Surveillance test, it achieved a 53.5% success rate, placing it between Opus 5 and GPT-5.6 Sol. These results suggest Grok 4.6 is well-calibrated for both helpful science and critical safety measures.

🍽️ Eating time matters for weight loss, say new studies

Time-restricted eating (TRE) may help maintain weight loss, according to a Spanish clinical trial involving 99 adults. This study, from University of Granada and Public University of Navarre, ran for 12 weeks, showing TRE groups lost 2.4 kg–2.6 kg more at 12 months. Separately, a US analysis of 31,000 adults linked delaying the first meal to higher mortality. Both studies suggest avoiding extreme eating times for better health outcomes. The advice is to make any eating strategy realistic and sustainable. 🍽️

❤️ Big updates in heart health and medicine

A new Fifth Universal Definition categorizes myocardial infarction into primary, secondary, or procedure-related types. Eli Lilly got FDA approval for tirzepatide to lower heart attack risk in Type 2 diabetes patients. In the AIR-STEMI trial, revascularization guided by functional angiography showed fewer major cardiovascular events. Inclisiran proved safer and more effective than bempedoic acid in lowering LDL cholesterol, per the VICTORION-Challenge trial. Allegations of misconduct surfaced against a former ESC president over conflicts of interest. 🩺

🎬 Bollywood's August box office dipped, but two films crushed it

Bollywood's total net collection fell by 17% in August 2026 compared to July's haul. Awarapan 2 and Hanuman Ansh emerged as major successes during this month in India. These films contributed 154 crore and 45.63 crore net, respectively, out of the total 255.29 crore. While Batwara 1947 disappointed, the success ratio improved with two hits this month. The next major releases, Mirzapur The Movie and Haiwaan, will be tracked in September.